Latest AstraZeneca News | Page 5 | The �Թ��վ Tribune

4 Nov 2022 5:03 pm AEST

Beyfortus approved in EU for prevention of RSV lower respiratory tract disease in infants

2 Nov 2022 5:09 pm AEST

AstraZeneca funds R&D Postdoctoral Challenge finalists

1 Nov 2022 5:03 pm AEST

Vaxzevria receives full Marketing Authorisation in EU for prevention of Covid

31 Oct 2022 7:03 pm AEST

AstraZeneca advances scientific leadership in cardiovascular and renal diseases with over 60 abstracts collectively

26 Oct 2022 4:09 pm AEST

Camizestrant significantly improved progression-free survival in advanced ER-positive breast cancer

26 Oct 2022 4:03 pm AEST

Capivasertib Phase III trial met primary endpoints

25 Oct 2022 4:06 pm AEST

Update on MESSINA Phase III trial for Fasenra in eosinophilic esophagitis

24 Oct 2022 4:06 pm AEST

Imjudo in combination with Imfinzi approved in US for patients with unresectable liver cancer

24 Oct 2022 7:48 am AEST

Budding pathologist untangling Covid vaccine response

20 Oct 2022 4:03 pm AEST

IDWeek data reinforces AstraZeneca’s commitment to advance science in vaccines and immune therapies

13 Oct 2022 1:15 pm AEST

Illumina and AstraZenca team up on AI-based research project

13 Oct 2022 10:36 am AEST

Myocarditis seven times more likely with Covid than vaccines

12 Oct 2022 7:15 pm AEST

Alexion aims to advance NMOSD treatment landscape with exceptional Ultomiris efficacy data at ECTRIMS 2022

11 Oct 2022 5:06 am AEST

How should we manage COVID without rules?

6 Oct 2022 9:45 am AEST

Pollen does more than make you sneeze

27 Sep 2022 4:09 pm AEST

Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type1

27 Sep 2022 4:03 pm AEST

Tezspire approved in Japan for treatment of severe asthma

23 Sep 2022 4:54 pm AEST

Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis

22 Sep 2022 4:06 pm AEST

Lynparza approved in China as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer

21 Sep 2022 4:06 pm AEST

Tezspire approved in EU for treatment of severe asthma

20 Sep 2022 4:03 pm AEST

Evusheld long-acting antibody combination approved in EU for treatment of Covid

19 Sep 2022 4:12 pm AEST

Treatment offers new hope for lupus – and maybe for other autoimmune diseases too

16 Sep 2022 4:30 pm AEST

Danicopan add-on to Ultomiris or Soliris met primary endpoint

16 Sep 2022 4:09 pm AEST

Evusheld long-acting antibody combination recommended for approval in EU for treatment of Covid

16 Sep 2022 4:06 pm AEST

Beyfortus recommended for approval in EU by CHMP for prevention of RSV lower respiratory tract disease in infants

13 Sep 2022 7:21 am AEST

New support for lung cancer patients

12 Sep 2022 4:06 pm AEST

Imfinzi plus chemotherapy further improved overall survival benefit in advanced biliary tract cancer

11 Sep 2022 6:24 pm AEST

Imfinzi and tremelimumab with chemotherapy demonstrated sustained survival benefit

11 Sep 2022 6:18 pm AEST

Enhertu continues to demonstrate clinically meaningful tumour response

11 Sep 2022 4:33 pm AEST

Tagrisso demonstrated 5.5-year median disease-free survival in adjuvant treatment of patients with EGFR-mutated lung cancer

9 Sep 2022 10:15 pm AEST

Lynparza in combination with bevacizumab, and as monotherapy, demonstrates clinically meaningful survival benefit

5 Sep 2022 4:09 pm AEST

Forxiga approved in China for treatment of chronic kidney disease in patients

5 Sep 2022 4:06 pm AEST

Imfinzi plus chemotherapy approved in US as first immunotherapy regimen for patients with advanced biliary tract cancer

5 Sep 2022 1:30 pm AEST

Covid vaccine difference between men and women

5 Sep 2022 6:15 am AEST

Better COVID vaccines are on way

31 Aug 2022 11:33 am AEST

First new treatment in more than 20 years added to PBS for people living with proteinuric chronic kidney disease

30 Aug 2022 10:03 pm AEST

Evusheld long-acting antibody combination approved for prevention and treatment of Covid in Japan

30 Aug 2022 4:03 pm AEST

Should states cut COVID isolation from 7 to 5 days?

28 Aug 2022 1:06 am AEST

New data show Farxiga significantly lowers risk of cardiovascular death in patients with heart failure

28 Aug 2022 12:33 am AEST

Farxiga significantly reduced risk of cardiovascular death or worsening of heart failure

25 Aug 2022 4:15 pm AEST

Ultomiris approved in Japan for treatment of adults with generalised myasthenia gravis

25 Aug 2022 4:06 pm AEST

Lynparza approved in Japan as adjuvant treatment for patients with BRCA-mutated HER2-negative high-risk early breast cancer

25 Aug 2022 10:48 am AEST

Victorian Government funding accelerates new approaches to vaccine development for ovarian cancer

25 Aug 2022 12:42 am AEST

Researchers identified markers of chemotherapy resistance and outcome in triple negative breast cancer

24 Aug 2022 4:06 pm AEST

AstraZeneca aims to transform cancer outcomes with new data across industry-leading portfolio at ESMO 2022

17 Aug 2022 3:36 pm AEST

Auditor general highlights vaccine rollout failures

16 Aug 2022 4:03 pm AEST

Lynparza in combination with abiraterone granted Priority Review in US for patients with metastatic castration-resistant prostate

15 Aug 2022 4:06 pm AEST